I would agree that some sort of partnership agreement is really what will “not disappoint” shareholders but the lack of any volume in trading suggests that is not the news. It would be great if Mr. Rae was on the cc the give the updates on partnerships, but he is not. I feel like it will be clinical news that normally would be great but won’t help the SP as usual. It is getting annoying the mgmt really thinks great clinical news will somehow bring a mythical inflection point, but partner support from the industry is the only thing that matters. I’m tempering my excitement, I hate that the unbelievable impact this drug will make on the world is completely negated by funding that mgmt can’t get done even with this polio vaccine level drug.